Molecular Imaging and Radionuclide Therapy

Scope & Guideline

Empowering knowledge in imaging and therapeutic advancements.

Introduction

Welcome to your portal for understanding Molecular Imaging and Radionuclide Therapy, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageMulti-Language
ISSN2146-1414
PublisherGALENOS PUBL HOUSE
Support Open AccessNo
CountryTurkey
TypeJournal
Convergefrom 2017 to 2024
AbbreviationMOL IMAGING RADIONUC / Mol. Imaging Radionucl. Ther.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKacamak Sokak 21/1, ISTANBUL, Findikzade 34093, TURKIYE

Aims and Scopes

The journal 'Molecular Imaging and Radionuclide Therapy' is dedicated to advancing the field of molecular imaging and therapy through innovative research that bridges nuclear medicine, radiology, and oncology. It emphasizes the importance of imaging techniques for diagnosis, treatment planning, and monitoring therapeutic responses in various malignancies and other diseases.
  1. Molecular Imaging Techniques:
    Focuses on the development and application of advanced imaging modalities, such as PET, SPECT, and CT, to visualize biological processes at the molecular and cellular levels.
  2. Radionuclide Therapy:
    Explores the therapeutic applications of radionuclides in treating various cancers, including the mechanisms of action, efficacy, and safety profiles of different radiopharmaceuticals.
  3. Diagnosis and Treatment Monitoring:
    Aims to improve diagnostic accuracy and treatment outcomes through imaging techniques that allow for the evaluation of treatment responses and the identification of disease recurrence.
  4. Clinical Applications in Oncology:
    Highlights the role of molecular imaging in oncology, particularly in the detection, characterization, and staging of tumors, as well as in personalized treatment approaches.
  5. Interdisciplinary Research:
    Encourages collaboration between researchers, clinicians, and industry to foster innovations in imaging and therapy, combining insights from nuclear medicine, radiology, and pathology.
The landscape of research in 'Molecular Imaging and Radionuclide Therapy' is evolving, with several emerging themes reflecting current trends in the field. These themes indicate areas of heightened interest and potential growth.
  1. Novel Radiopharmaceuticals:
    A growing body of research is focusing on the development and clinical application of novel radiopharmaceuticals, particularly those targeting specific molecular markers in cancers.
  2. Theranostics:
    The integration of therapeutic and diagnostic approaches, known as theranostics, is increasingly prevalent, allowing for personalized treatment strategies based on imaging findings.
  3. Artificial Intelligence in Imaging:
    The application of artificial intelligence and machine learning techniques for image analysis and interpretation is emerging as a significant trend, enhancing diagnostic accuracy and workflow efficiency.
  4. Immuno-PET Imaging:
    Research on immuno-PET, which combines immunotherapy with PET imaging to monitor treatment response, is gaining traction as a promising area for personalized cancer management.
  5. Radiomics and Texture Analysis:
    The use of radiomics to extract quantitative features from imaging data for predicting treatment outcomes and tumor characteristics is increasingly popular, reflecting the trend towards data-driven approaches in oncology.

Declining or Waning

While the journal maintains a strong focus on cutting-edge research, certain themes have seen a decline in prominence over recent years. This section identifies these waning scopes, reflecting shifts in research interests and advancements in technology.
  1. Non-Oncological Applications:
    Research focusing on non-oncological applications of molecular imaging and radionuclide therapy has decreased, as the field has increasingly concentrated on oncology-related studies.
  2. Older Imaging Techniques:
    There is a noticeable decline in publications centered around older imaging techniques that have been largely supplanted by more advanced methodologies, such as PET/CT and hybrid imaging.
  3. Basic Science Studies:
    The journal has shifted towards more clinically oriented research, resulting in fewer publications that focus solely on the basic science aspects of imaging and therapy.
  4. Traditional Radiopharmaceuticals:
    Research on traditional radiopharmaceuticals that do not incorporate newer imaging technologies or innovative therapeutic approaches is becoming less frequent.

Similar Journals

BMC MEDICAL IMAGING

Empowering Researchers and Clinicians in Medical Imaging.
Publisher: BMCISSN: 1471-2342Frequency: 1 issue/year

BMC Medical Imaging is a premier open-access journal dedicated to advancing the field of radiology, nuclear medicine, and imaging technologies. Published by BMC in the United Kingdom, this journal serves as a vital resource for researchers, clinicians, and students, fostering a collaborative environment for sharing innovative findings and methodologies in medical imaging. With a commendable impact factor and an impressive Scopus ranking within the top 35% of its category, BMC Medical Imaging provides a platform for high-quality research to be disseminated widely and freely since its inception in 2001. The journal aims to cover a diverse array of topics, from advanced imaging techniques to their clinical applications, enhancing the understanding and effectiveness of diagnostic practices. By contributing to the body of knowledge and facilitating open access to research, BMC Medical Imaging plays a pivotal role in shaping the future of medical imaging and improving patient care.

NUKLEARMEDIZIN-NUCLEAR MEDICINE

Exploring the Depths of Nuclear Medicine Research.
Publisher: GEORG THIEME VERLAG KGISSN: 0029-5566Frequency: 6 issues/year

NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Fostering Excellence in Nuclear Medicine Research
Publisher: SPRINGERISSN: 1619-7070Frequency: 12 issues/year

The European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.

Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique

Transforming Knowledge in Functional and Metabolic Imaging.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0928-1258Frequency: 6 issues/year

Medicine Nucleaire-Imagerie Fonctionnelle et Metabolique is a prominent journal published by Elsevier France-Editions Scientifiques Medicales Elsevier, dedicated to the specialized fields of nuclear medicine and functional imaging. With an ISSN of 0928-1258 and an E-ISSN of 1878-6820, this esteemed publication has been a crucial platform for the dissemination of research and developments in the discipline since its inception in 1993. Covering a wide array of topics within biophysics, radiological and ultrasound technology, and radiology, the journal currently holds a Q4 category ranking in these fields, reflecting its significance within the academic community. Although there are currently no open access options available for readers, the journal caters to a niche audience of researchers, professionals, and students who seek to enhance their understanding of metabolic imaging and its applications. The 2023 Scopus ranks indicate its position as an emerging source of knowledge in a competitive landscape, making it an important resource for the latest studies and innovations in nuclear medicine.

Iranian Journal of Radiology

Elevating Diagnostic Imaging with Quality Insights
Publisher: BRIEFLANDISSN: 1735-1065Frequency: 4 issues/year

Welcome to the Iranian Journal of Radiology, a pivotal platform dedicated to advancing the field of radiology, nuclear medicine, and medical imaging. Published by BRIEFLAND, this journal aims to disseminate high-quality original research, reviews, and clinical studies that contribute substantially to the global scientific community. Established in 2008 and spanning until 2024, the journal provides an essential archive of knowledge in a rapidly evolving discipline. Although it currently holds a Q4 quartile ranking in the 2023 Scopus metrics, it serves as an important resource for both emerging and established researchers looking to submit their work. Located in the Netherlands, the journal is committed to open dialogue and collaboration amongst professionals in the field, reflecting its accessibility and relevance to both practitioners and academics. With its continued growth and commitment to quality, the Iranian Journal of Radiology is poised to enhance understanding and innovation in diagnostic imaging.

Tomography

Bridging the gap between research and clinical application.
Publisher: MDPIISSN: 2379-1381Frequency: 6 issues/year

Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.

BRITISH JOURNAL OF RADIOLOGY

Exploring New Frontiers in Nuclear Medicine and Imaging
Publisher: BRITISH INST RADIOLOGYISSN: 0007-1285Frequency: 12 issues/year

British Journal of Radiology is a leading peer-reviewed journal published by the British Institute of Radiology, dedicated to advancing the field of radiology, nuclear medicine, and imaging. With a prestigious history dating back to 1945, this journal is at the forefront of disseminating cutting-edge research and innovations that significantly impact clinical practice. Currently enjoying a Q1 ranking in the field of radiology and Q2 in general medicine for 2023, it is recognized for its rigorous standards and high-quality content, ranking #87 out of 333 in Scopus for specialties related to Medicine, Radiology, Nuclear Medicine, and Imaging, placing it in the 74th percentile. Researchers, professionals, and students are encouraged to engage with the latest findings and comprehensive reviews presented within its pages, which contribute not only to academic discourse but also to the evolution of practice in the wider medical community.

World Journal of Nuclear Medicine

Pioneering Knowledge in Nuclear Medicine's Evolving Landscape
Publisher: THIEME MEDICAL PUBL INCISSN: 1450-1147Frequency: 4 issues/year

World Journal of Nuclear Medicine, published by THIEME MEDICAL PUBL INC, is a premier peer-reviewed journal dedicated to advancing the field of nuclear medicine. With an Open Access model established since 2011, this journal ensures that high-quality research is accessible to a wide audience, fostering knowledge sharing and collaboration among researchers, clinicians, and students alike. The journal aims to publish innovative studies, reviews, and clinical trials that contribute significantly to both the theoretical and practical aspects of nuclear medicine, enhancing diagnostic and therapeutic techniques within this critical area of healthcare. As the journal continues to grow in visibility and impact, it remains an essential resource for those seeking to stay at the forefront of advancements in nuclear medicine.

SEMINARS IN NUCLEAR MEDICINE

Fostering collaboration for enhanced patient outcomes.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0001-2998Frequency: 6 issues/year

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Elevating Research in Nuclear Medicine and Imaging.
Publisher: EDIZIONI MINERVA MEDICAISSN: 1824-4785Frequency: 4 issues/year

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.